Bridgewater Associates LP Lowers Stock Holdings in Phreesia, Inc. (NYSE:PHR)

Bridgewater Associates LP reduced its holdings in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 51.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,445 shares of the company's stock after selling 31,869 shares during the quarter. Bridgewater Associates LP owned 0.05% of Phreesia worth $694,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of PHR. International Assets Investment Management LLC boosted its stake in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company's stock valued at $33,000 after buying an additional 1,395 shares during the period. nVerses Capital LLC lifted its stake in Phreesia by 76.5% in the second quarter. nVerses Capital LLC now owns 3,000 shares of the company's stock worth $64,000 after acquiring an additional 1,300 shares during the period. Lombard Odier Asset Management USA Corp purchased a new position in shares of Phreesia during the second quarter valued at about $202,000. Point72 DIFC Ltd bought a new position in shares of Phreesia in the 2nd quarter worth approximately $209,000. Finally, Hsbc Holdings PLC bought a new position in Phreesia in the second quarter worth $301,000. Institutional investors own 92.10% of the company's stock.

Analysts Set New Price Targets

A number of research firms have weighed in on PHR. DA Davidson restated a "buy" rating and set a $32.00 price objective on shares of Phreesia in a research note on Thursday, September 5th. JMP Securities reissued a "market outperform" rating and set a $30.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Royal Bank of Canada restated a "sector perform" rating and set a $23.00 target price on shares of Phreesia in a research note on Friday, September 27th. Canaccord Genuity Group restated a "buy" rating and issued a $34.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Finally, Robert W. Baird upped their target price on shares of Phreesia from $31.00 to $34.00 and gave the stock an "outperform" rating in a research report on Friday, September 6th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $29.42.

Insider Buying and Selling

In related news, CEO Chaim Indig sold 5,295 shares of the stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $123,108.75. Following the completion of the sale, the chief executive officer now owns 1,223,736 shares of the company's stock, valued at approximately $28,451,862. This trade represents a 0.43 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP David Linetsky sold 1,716 shares of the company's stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $23.25, for a total value of $39,897.00. Following the completion of the sale, the senior vice president now owns 203,318 shares of the company's stock, valued at approximately $4,727,143.50. The trade was a 0.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 29,997 shares of company stock worth $667,943. Insiders own 5.80% of the company's stock.

Phreesia Trading Down 0.9 %

Shares of NYSE PHR traded down $0.20 during trading on Tuesday, reaching $20.90. 296,105 shares of the company traded hands, compared to its average volume of 445,391. Phreesia, Inc. has a 12-month low of $14.55 and a 12-month high of $29.16. The firm's fifty day simple moving average is $20.43 and its 200 day simple moving average is $21.84. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.77 and a current ratio of 1.77.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share for the quarter, topping analysts' consensus estimates of ($0.37) by $0.06. The company had revenue of $102.12 million during the quarter, compared to analysts' expectations of $101.76 million. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. As a group, equities analysts expect that Phreesia, Inc. will post -1.23 earnings per share for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.